Protgen Ltd
Clinical trials sponsored by Protgen Ltd, explained in plain language.
-
New protein treatment for liver swelling shows promise in early trial
Disease control CompletedThis early-phase study tested a lab-made version of a natural protein (human serum albumin) in 36 adults with liver cirrhosis and fluid buildup in the belly (ascites). The goal was to check safety and how the body processes the drug at three different doses. Participants received…
Phase: PHASE1 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated May 26, 2026 07:51 UTC
-
New Lab-Made protein could help liver patients retain fluids safely
Disease control CompletedThis study tested a lab-made version of human serum albumin (rHSA) against the standard human albumin in 92 adults with liver cirrhosis and mild to moderate fluid buildup in the belly (ascites). The goal was to see if rHSA can safely raise blood albumin levels and reduce fluid. B…
Phase: PHASE2, PHASE3 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Lab-Made protein could replace donor albumin for liver patients
Disease control CompletedThis study tested if a lab-made version of the protein albumin works as well as the standard human-derived albumin for treating fluid buildup (ascites) in people with advanced liver disease. About 390 adults with cirrhosis and ascites took part. The goal was to see if the lab-mad…
Phase: PHASE2, PHASE3 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lab-Made albumin passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a lab-made version of human serum albumin in 48 healthy adults to see if it is safe and how the body handles it. Participants received a single dose of either the test drug or a placebo. The goal is to gather safety data before testing it as a treatm…
Phase: PHASE1 • Sponsor: Protgen Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 07:36 UTC